HTSC(06886.HK)成立合夥企業 投資醫療健康行業
HTSC(06886.HK)公布關連交易,董事會批准全資附屬公司華泰紫金與江蘇投管、南京產業基金及北聯創業投資成立合夥企業以創立基金,所有合夥人向合夥企業繳付之總出資額為30億元人民幣,佔比分別為20%、40%、20%及20%,為基金初期認繳規模。
基金以醫療健康行業為主要投資方向,包括生物醫藥、醫療器械、醫療服務等領域。
根據合夥協議,華泰紫金擔任基金管理人,向合夥企業提供投資諮詢、投資管理和其他服務,合夥企業向華泰紫金支付基金管理費。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.